Evidence map›Paper›PMID 34648374›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2022

Modern approaches on stem cells and scaffolding technology for osteogenic differentiation and regeneration.

Shivaani Kirankumar, Narasimman Gurusamy, Sheeja Rajasingh, Vinoth Sigamani, Jayavardini Vasanthan, Selene G Perales, Johnson Rajasingh

Open access · greenAbstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shivaani KirankumarDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Narasimman GurusamyDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Sheeja RajasinghDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Vinoth SigamaniDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0002-7545-3907
Jayavardini VasanthanDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Selene G PeralesDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Johnson RajasinghDepartment of Bioscience Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0002-6172-4083
University of Tennessee Health Science Center · USSRM Institute of Science and Technology · IN

Funding

scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy PatientsR01HL141345 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JOHNSON, RAJASINGH · 2019 to 2022
$1.5M
NHLBI NIH HHS R01 HL141345
6 · The paper itself

Abstract

The process of bone repair has always been a natural mystery. Although bones do repair themselves, supplemental treatment is required for the initiation of the self-regeneration process. Predominantly, surgical procedures are employed for bone regeneration. Recently, cell-based therapy for bone regeneration has proven to be more effective than traditional methods, as it eliminates the immune risk and painful surgeries. In clinical trials, various stem cells, especially mesenchymal stem cells, have shown to be more efficient for the treatment of several bone-related diseases, such as non-union fracture, osteogenesis imperfecta, osteosarcoma, and osteoporosis. Furthermore, the stem cells grown in a suitable three-dimensional scaffold support were found to be more efficient for osteogenesis. It has been shown that the three-dimensional bioscaffolds support and simulate an

Indexed as

OsteogenesisTissue ScaffoldsBone RegenerationCell DifferentiationCells, CulturedHumansStem CellsTechnologybone regenerationosteogenic differentiationscaffoldsStem cells

Identifiers

PMID34648374
PMCPMC8919323
OpenAlexW3207860446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.